Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Immunity, Inflammation and Disease
|
May 30, 2023
CRISPR/Cas9 for hepatitis B virus infection treatment
Bo Cai, Shixue Chang, Yuhan Tian, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
September 27, 2021
Postoperative Neutrophil-to-Lymphocyte Ratio Is Associated with Mortality in Adult Patients After Cardiopulmonary Bypass Surgery: A Cohort Study
Yanhong Zhu, Wenyong Peng, Shuai Zhen, et al.
Human Gene Therapy
|
November 21, 2018
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
Shuai Zhen, Jiaojiao Lu, Wei Chen, et al.
BMC Evolutionary Biology
|
January 5, 2012
Nuclear and plastid haplotypes suggest rapid diploid and polyploid speciation in the N Hemisphere Achillea millefolium complex (Asteraceae)
Yan-Ping Guo, Shuai-Zhen Wang, Claus Vogl, et al.
Taiwanese Journal of Obstetrics & Gynecology
|
January 2, 2017
Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21<sup>Waf1/Cip1</sup> and p27<sup>Kip1</sup>
Yuanyuan Zhou, Ke Wang, Shuai Zhen, et al.
Molecular and Clinical Oncology
|
June 19, 2014
Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis
Shuai Zhen, Li-Hong Bian, Li-Li Chang, et al.
Sensors (Basel, Switzerland)
|
May 27, 2026
Intelligent Extraction of Minimum Burden in Medium-Length Hole Blasting Using Combined Region Growing and DBSCAN
Yu Bai, Yachun Mao, Shuai Zhen, et al.
Current Cancer Drug Targets
|
June 16, 2026
FDFT1 Suppresses Ovarian Tumorigenesis and Overcomes Cisplatin Resistance by Activating Ferroptosis Through the NRF2/GPX4/SLC7A11 Axis
Yu Jiang, Pincheng Li, Ximu Xiao, et al.
Cancer Gene Therapy
|
August 29, 2019
Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Shuai Zhen, Jiaojiao Lu, Yun-Hui Liu, et al.
Oncotarget
|
December 29, 2016
Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome
Shuai Zhen, Yoichiro Takahashi, Shunichi Narita, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Immunity, Inflammation and Disease
|
May 30, 2023
CRISPR/Cas9 for hepatitis B virus infection treatment
Bo Cai, Shixue Chang, Yuhan Tian, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
September 27, 2021
Postoperative Neutrophil-to-Lymphocyte Ratio Is Associated with Mortality in Adult Patients After Cardiopulmonary Bypass Surgery: A Cohort Study
Yanhong Zhu, Wenyong Peng, Shuai Zhen, et al.
Human Gene Therapy
|
November 21, 2018
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
Shuai Zhen, Jiaojiao Lu, Wei Chen, et al.
BMC Evolutionary Biology
|
January 5, 2012
Nuclear and plastid haplotypes suggest rapid diploid and polyploid speciation in the N Hemisphere Achillea millefolium complex (Asteraceae)
Yan-Ping Guo, Shuai-Zhen Wang, Claus Vogl, et al.
Taiwanese Journal of Obstetrics & Gynecology
|
January 2, 2017
Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21<sup>Waf1/Cip1</sup> and p27<sup>Kip1</sup>
Yuanyuan Zhou, Ke Wang, Shuai Zhen, et al.
Molecular and Clinical Oncology
|
June 19, 2014
Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis
Shuai Zhen, Li-Hong Bian, Li-Li Chang, et al.
Sensors (Basel, Switzerland)
|
May 27, 2026
Intelligent Extraction of Minimum Burden in Medium-Length Hole Blasting Using Combined Region Growing and DBSCAN
Yu Bai, Yachun Mao, Shuai Zhen, et al.
Current Cancer Drug Targets
|
June 16, 2026
FDFT1 Suppresses Ovarian Tumorigenesis and Overcomes Cisplatin Resistance by Activating Ferroptosis Through the NRF2/GPX4/SLC7A11 Axis
Yu Jiang, Pincheng Li, Ximu Xiao, et al.
Cancer Gene Therapy
|
August 29, 2019
Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Shuai Zhen, Jiaojiao Lu, Yun-Hui Liu, et al.
Oncotarget
|
December 29, 2016
Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome
Shuai Zhen, Yoichiro Takahashi, Shunichi Narita, et al.
Page
of 5